Typically large companies on OTC are foreign represented as an ADR so yes we are doing quite well for a company not traded on an overseas exchange. OTC companies are usually much smaller in market cap than NWBO as we are today. That means a lot of smart money are behind DCVax.
Yet if you consider the market potential of our intellectual property we are certainly undervalued by at least 9 billion at this pre-approval yet proven efficacy stage. Our price remains stagnant because we need more buyers.
OTC acts as a barrier to entry as only the most risk taking investors like Michael Bigger, Steve Derby, and Robert Heffner are willing to front run everyone else to mine this gold before it's revealed to the broader investment community. There's simply a limited number of investors of this caliber willing to risk capital at this stage.
On the flip side thank Linda Powers for delisting to OTC which provided us this one in a lifetime arbitrage opportunity! We have less competition for shares! I don't think we will be here much longer. Buy what you can without threat of divorce. She will thank you later in my personal opinion.
Do your own research. I am not providing legal or investment advice. This is an anonymous forum for entertainment purposes only. Don't trust anything you read.
AI
